Author

Erica Lynne Braverman

University of PittsburghORCID 0000-0002-5072-5291Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Aaron Yang· 1 shared Allison MacLean· 1 shared Amanda C. PoholekiD· 1 shared Ann Titus· 1 shared Archana Ramgopal· 1 shared Bhavya Kanagala· 1 shared Christopher Wittmann· 1 shared Craig ByersdorferiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aaron Yang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

AMPK agonism optimizes the in vivo persistence and anti-leukemia efficacy of chimeric antigen receptor T cells

Erica Lynne Braverman, Mengtao Qin, Elisabet Ampudia-Mesias, Herbert Tres Schuler, Harrison Brown, Lukas Murdych, Ann Titus, Allison MacLean, Bhavya Kanagala, Christopher Wittmann, Archana Ramgopal, Felicia Kemp, Steven J Mullet, Aaron Yang, Amanda C. Poholek, , Craig Byersdorfer

This study shows that activating AMPK during CAR T cell expansion improves their in vivo persistence and anti-leukemia efficacy without altering expansion protocols or genetic constructs.

Journal for ImmunoTherapy of Cancer · Dec 1, 2025Peer-reviewedImmunology